📄 medicine

TSH-induced post thyroidectomy spontaneous ovarian hyperstimulation syndrome: a rare case report of molecular mimicry

This case report describes a rare instance of spontaneous ovarian hyperstimulation syndrome in a post-thyroidectomy patient, caused by extreme TSH levels cross-activating FSH receptors via molecular mimicry, which was successfully resolved through levothyroxine replacement and supportive care without surgical intervention.

Original authors: Jose Luis Rojas-Oviedo, María Fernanda Leal Walteros, Dauris Lineth Mejía Pérez, Jorge Eliecer Castellanos Corredor, Diana Carolina Vargas Fiesco, Juan Carlos Vallejo-Soto, Valentina Marín Henao

Published 2026-07-07

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Jose Luis Rojas-Oviedo, María Fernanda Leal Walteros, Dauris Lineth Mejía Pérez, Jorge Eliecer Castellanos Corredor, Diana Carolina Vargas Fiesco, Juan Carlos Vallejo-Soto, Valentina Marín Henao

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The Big Picture: A Case of "Wrong-Number" Hormones

Imagine your body is a high-tech factory with a central control room (the brain) and various departments (organs). Usually, the control room sends specific messengers (hormones) to specific departments with clear instructions.

This paper tells the story of a 26-year-old woman whose factory got into a bit of chaos because one of the messengers got lost, multiplied, and started knocking on the wrong doors.

The Backstory: The Missing Switch

Ten years ago, this woman had her thyroid gland removed because of cancer. The thyroid is like a thermostat for the body's metabolism. Since she didn't have one, she needed to take a daily pill (levothyroxine) to replace the missing thermostat.

However, she had been forgetting to take her pills. Because the "thermostat" was missing and she wasn't taking the replacement, her body's control room panicked. It thought, "We have no heat! We need more heat!" So, it started screaming orders, sending out massive amounts of a messenger called TSH (Thyroid-Stimulating Hormone) to try to find a thyroid that wasn't there.

The Mix-Up: The "Specificity Spillover"

Here is where the confusion happened.

In the body, TSH is supposed to talk to the thyroid. But TSH looks a lot like another messenger called FSH (Follicle-Stimulating Hormone), which is supposed to talk to the ovaries. Think of them as two keys that look 90% identical.

Because the woman's body was screaming so loudly (her TSH levels were astronomically high), the TSH messengers got so crowded that they started jamming into the wrong locks. They tried to open the doors meant for FSH.

This is what the doctors call "Specificity Spillover." It's like a flood of people trying to get into a building; eventually, they spill over and push open the emergency exit meant for a different building.

The Result: The Ovarian "Party"

The ovaries have a door labeled "FSH." When the TSH messengers forced their way in, the ovaries thought, "Oh, we've been invited to a party!"

They started working overtime. They grew huge, filled with fluid-filled sacs (cysts), and swelled up like over-inflated balloons. This caused:

Severe belly pain: Because the ovaries were so big they were pressing on everything.
Ascites (Fluid in the belly): The ovaries leaked fluid into the abdominal cavity, like a sponge that got too wet and started dripping everywhere.
Diarrhea and vomiting: The swollen organs were squeezing the digestive tract.

The Diagnosis: Avoiding a Mistake

When she went to the emergency room, the doctors saw the huge cysts and fluid. In many cases, this looks exactly like ovarian cancer. The doctors might have thought, "We need to cut this out immediately."

However, they also checked her blood and found something strange:

Her TSH was through the roof (150 mIU/mL).
Her actual FSH levels were normal.
She wasn't pregnant.

The doctors realized this wasn't cancer. It was a rare condition called Spontaneous Ovarian Hyperstimulation Syndrome (Type III). It was caused entirely by her missing thyroid medication.

The Solution: Fix the Thermostat

The doctors didn't need to perform surgery to remove the ovaries. Instead, they treated the root cause:

They gave her the thyroid medication she had been missing.
They gave her fluids to help her body rehydrate.
They gave her blood thinners to prevent clots (because the fluid shift makes blood thick and sticky).

Once she started taking her thyroid pills, the control room stopped screaming. The TSH levels dropped, the "wrong-key" messengers stopped knocking on the ovarian doors, and the ovaries slowly shrank back to normal size. The fluid disappeared, and she went home feeling better.

The Takeaway

This story teaches us that sometimes, when a patient has a swollen belly and strange cysts, the problem isn't a tumor in the ovaries—it might be a missing thyroid pill.

If doctors recognize this "wrong-key" mix-up early, they can avoid unnecessary surgeries and simply fix the hormone balance, letting the body heal itself. It's a reminder that the body's systems are all connected, and a problem in one area (the thyroid) can cause a chaotic party in another (the ovaries).

Technical Summary: TSH-induced Post-thyroidectomy Spontaneous Ovarian Hyperstimulation Syndrome

Problem Statement
Spontaneous Ovarian Hyperstimulation Syndrome (sOHSS) is an exceptionally rare clinical entity, distinct from the common iatrogenic form associated with assisted reproductive technology (ART). While iatrogenic OHSS is triggered by exogenous human chorionic gonadotropin (hCG), sOHSS occurs without ovulation induction. The paper focuses specifically on Type III sOHSS, a rare condition directly linked to profound, untreated primary hypothyroidism. This condition is often misdiagnosed as ovarian malignancy or other adnexal pathologies due to the presence of bilateral multicystic ovarian enlargement, massive ascites, and elevated tumor markers (CA-125). The core clinical challenge lies in distinguishing this reversible endocrine disorder from surgical emergencies to avoid unnecessary interventions such as oophorectomy or transsphenoidal resection.

Methodology
This study presents a single-case report of a 26-year-old female with a history of total thyroidectomy for papillary carcinoma performed ten years prior. The patient presented to the emergency department with severe abdominal pain, diarrhea, vomiting, and tense ascites. The diagnostic approach involved:

Clinical Evaluation: Assessment of physical symptoms and history of suboptimal levothyroxine adherence.
Imaging: Contrast-enhanced CT scanning to visualize adnexal masses and fluid distribution.
Laboratory Analysis: Comprehensive endocrine profiling including Thyroid-Stimulating Hormone (TSH), Free T4 (FT4), Follicle-Stimulating Hormone (FSH), estradiol, prolactin, and CA-125 levels. A pregnancy test was also conducted to rule out gestational causes.
Management Protocol: The patient was managed through a three-pillar approach: (1) Hormonal stabilization via immediate re-initiation and titration of levothyroxine; (2) Fluid and electrolyte management using intravenous crystalloids to restore intravascular volume; and (3) Symptomatic therapy including diuretics and thromboprophylaxis with low molecular weight heparin (LMWH).

Key Contributions and Mechanism
The paper elucidates the pathophysiological mechanism of "specificity spillover" in Type III sOHSS. The authors explain that TSH, FSH, LH, and hCG belong to the glycoprotein hormone family, sharing an identical $\alpha$ -subunit and $\beta$ -subunits with over 40% amino acid sequence homology. In the absence of negative feedback following a thyroidectomy, the body hypersecretes TSH, reaching extreme concentrations (in this case, 150 mIU/mL). At these levels, TSH cross-reacts with and activates wild-type FSH receptors on ovarian granulosa cells. This molecular mimicry stimulates follicular recruitment and cystic enlargement, mimicking FSH-mediated hyperstimulation without elevated FSH levels.

Additionally, the paper highlights the metabolic consequences of severe hypothyroidism, including a shift in estrogen metabolism toward the production of weaker estriol, which further reduces negative feedback and drives gonadotropin release. Elevated Thyrotropin-Releasing Hormone (TRH) also stimulates pituitary lactotrophs, causing hyperprolactinemia, which sensitizes the ovaries to gonadotropic stimulation.

Results
The patient presented with:

Hormonal Profile: Severe primary hypothyroidism (TSH 150 mIU/mL, FT4 0.23 mIU/mL), elevated estradiol (589.91 pg/mL), mild hyperprolactinemia (87.17 ng/mL), and normal FSH (7.14 mIU/mL).
Imaging: Bilateral complex adnexal cystic masses (Right: 118 x 62 mm; Left: 69 x 84 mm) and massive ascites.
Tumor Markers: Elevated CA-125 (49.50 U/mL), a finding attributed to peritoneal stretching rather than malignancy.

Following the initiation of levothyroxine replacement and supportive care, the patient exhibited a favorable clinical evolution. Gastrointestinal symptoms resolved, abdominal pain decreased significantly, and the patient was discharged in stable condition. The authors note that the management strategy led to the complete resolution of symptoms and radiologic findings, with the expectation of ovarian cyst regression as the patient achieved a euthyroid state.

Significance
The paper asserts that the recognition of severe primary hypothyroidism as a reversible cause of sOHSS is vital for clinical practice. The primary significance lies in the prevention of unnecessary and potentially disastrous surgical interventions (e.g., oophorectomy) that might be performed if the condition is misdiagnosed as ovarian cancer or a pituitary macroadenoma (due to compensatory thyrotrophic hyperplasia). The authors emphasize that early endocrine diagnosis via thyroid function testing is the critical differentiator. The case reinforces that the gold standard for management is levothyroxine replacement combined with meticulous supportive care, which ensures excellent clinical outcomes and the complete resolution of the syndrome without invasive procedures.